Conor Bradley retweeted
Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
Conor Bradley retweeted
@TheBHF CorCTCA trial - coronary function tests clarify the cause of angina in patients with #ANOCA. Great work @NovaliaSidik @JubileeHospital @UofGMVLS 🙏 thanks to our patients 🙏
Conor Bradley retweeted
The choice of @trussliz as PM increases the odds the UK will distance itself more from/adopt an inflexible stance toward the EU, increasing the odds the UK one day unravels (losing either Scotland or NI or both). This and a weaker economy will be the ultimate legacy of Brexit.
Conor Bradley retweeted
I’ve been thinking about this piece for a year. There’s so much more I could say. The only thing that matters is that Martha should be alive today…
‘We had such trust, we feel such fools’: how shocking hospital mistakes led to our daughter’s death theguardian.com/lifeandstyle…
Conor Bradley retweeted
No benefit of PCI Vs OMT in the @REVIVED_BCIS2 trial in the risk of death or HF hospitalisation in patients with CAD and HFrEF
Huge Glasgow input led by @markcpetrie20 with 83 patients randomised at @JubileeHospital
Online now @NEJM nejm.org/doi/full/10.1056/NE…
Conor Bradley retweeted
Huge congratulations to our iCorMicA colleagues in Cork for randomising the first two Irish & EU patients! iCorMicA is a study investigating the role of microvascular function testing in the management of patients with INOCA. #icormica #INOCA @barryhennigan @ColinBerryMD – at Cork, Ireland










